Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 12, 2008 1:38:59 PM CDT

Learn about Newser Points »

Stories related to: biotechnology

Stories

8 Stories

  • September 2008

    • Our Economic Cure? Innovation

      BusinessWeek  |  Sep 14, 08 1:37 PM CDT

      Our Economic Cure? Innovation

      (Newser) - Democrats and Republicans do have something in common: Both parties are wrong on how to resuscitate the flat-lining US economy, Michael Mandel argues in BusinessWeek . Tax cuts or increased government spending aren’t the cure. “Innovation is the best—and maybe the only—way the US can get out of its economic hole,” Mandel insists, adding that money alone isn’t enough. More »

      Tags

      China  • Republicans  • Democrats  • India  • trade  • tax cuts  • innovation  • nanotechnology  • information technology  • biotechnology  • foreign oil  • economist  • US productivity  • research and development

  • February 2008

    • Arabs Building First Green City

      BBC  |  Feb 10, 08 5:14 PM CST

      Arabs Building First Green City

      (Newser) - Earth's first carbon-free city is being built in the United Arab Emirates and will take 8 years and $22 billion to complete, the BBC reports. Called Masdar City, it will run on solar power and shuttle residents on travel pods via magnetic tracks. But critics say the $22 billion project, funded by the city of Abu Dhabi, belies the oil-rich emirate's overall gobbling of resources. More »

      Tags

      Abu Dhabi  • clean energy  • United Arab Emirates  • green  • biotechnology  • sustainability

  • January 2008

    • 10 Life-Changing Innovations

      LiveScience  |  Jan 20, 08 12:33 PM CST

      10 Life-Changing Innovations

      (Newser) - From omnipresent Internet to cloned donor organs, LiveScience picks 10 new technologies that, when fully developed, will transform our lives. Digital libraries: When all of humanity's texts are digitized, any factual question will be answerable online. Gene therapy/stem cells: The key to curing some of our nastiest afflictions. Ubiquitous wireless Internet: WiMAX and 3G point the way to a future where communication between any two devices is possible. Mobile robots: Too lazy to go to the store? Just send your car! More »

      Tags

      list  • Wi-Fi  • green technology  • cloning  • information technology  • hydrogen fuel cells  • biotechnology  • WiMAX  • Moore's Law

    • Street Yawns at Genentech Quarterlies

      Associated Press  |  Jan 15, 08 11:09 AM CST

      Street Yawns at Genentech Quarterlies

      (Newser) - Drug maker Genentech – struggling with near-flat sales of its two premier drugs, Avastin and Rituxan – managed to outperform analyst’s fourth quarter expectations – barely, reports the Associated Press. The one-time biotech uber star, which recorded phenomenal growth in each of the two previous years, showed only a 6.4% increase in profits on sales that rose 9% in the quarter. More »

      Tags

      earnings reports  • pharmaceutical  • biotechnology  • Genentech  • Avastin

    • Merck May Pay $700M for Schizophrenia Drug

      Reuters  |  Jan 3, 08 11:42 AM CST

      Merck May Pay $700M for Schizophrenia Drug

      (Newser) - Merck today finalized a deal worth as much as $700 million to license a schizophrenia drug from Swiss biotech firm Addex Pharmaceuticals. Addex will get $22 million up front, and qualify for another $680 million in milestone payments. Such licensing deals are growing commonplace, Reuters reports, as big pharma turns to little biotech to refill drug pipelines. More »

      Tags

      pharmaceutical companies  • Merck  • schizophrenia  • biotechnology  • psychotherapy

  • August 2007

    • Biotech Giant Slashes Jobs

      Wall Street Journal  |  Aug 16, 07 1:34 AM CDT

      Biotech Giant Slashes Jobs

      (Newser) - Biotech giant Amgen is slashing spending by $1.9 billion by cutting up to 14 percent of its workforce— 2,600 jobs—and closing some production facilities. The restructuring was triggered by plummeting sales of the company's anemia drug Aranesp. The shake up demonstrates that biotech operations are not immune to the problems that plague traditional drug companies, the Wall Street Journal reports. More »

      Tags

      biotechnology  • Genentech  • restructuring  • Roche Holding  • Cera  • Amgen

    • 10 Technologies on the Cusp

      MIT Technology Review  |  Aug 5, 07 2:33 PM CDT

      10 Technologies on the Cusp

      (Newser) - Technology Review presents 10 technologies you'll soon be hearing about. Peer-to-peer networking as a way for legitimate businesses to handle heavy data streaming. Nanocharging solar, which could make solar power cost-competitive. Artifically structured metamaterials. Personalized medical monitors. Single-cell analysis. More »

      Tags

      list  • technology  • science  • medical breakthrough  • solar energy  • biotechnology

  • June 2007

    • Scientists on the Brink of Artificial Life

      Daily Telegraph (UK)  |  Jun 29, 07 7:30 AM CDT

      Scientists on the Brink of Artificial Life

      (Newser) - The first artificial life could be created within months as researchers emboldened by "species transplant" experiments prepare to insert synthetic genomes into a host bacterium, the Daily Telegraph reports. Maryland scientists have been replacing one bacterium's DNA with another, transforming the host  into the invader, and now plan to do the same with a lab-created genome. More »

      Tags

      science  • DNA  • biofuel  • bacteria  • biotechnology

8 Stories

Today's Most Popular

Loading...

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »